Axon Enterprise Inc's current price of $391.88 is supported by a significant market cap of $31.59B, but the company's weak EPS growth of -39.57% raises concerns about its profitability. Despite a revenue growth of 34.00%, the high P/E ratio of 153.34 suggests the stock may be overvalued given its recent earnings misses, including Q1 2026 where actual EPS of $1.61 fell short of the estimate of $1.63.
Investors should exercise caution and consider a wait-and-see approach before entering the Axon stock due to its recent performance and high valuation metrics.
If Axon can reverse its negative EPS growth trend and leverage its impressive revenue growth of 34.00%, it could enhance profitability and attract more investors. The analyst consensus is also optimistic with 25 out of 28 analysts rating the stock as either Strong Buy or Buy, signaling potential upside.
On the bearish side, Axon's recent earnings misses, particularly the Q1 2026 miss where actual EPS was $1.61 against an estimate of $1.63, indicate challenges in meeting market expectations. Additionally, a high P/E ratio of 153.34 suggests that the stock may be overvalued, particularly in light of its deteriorating EPS growth of -39.57%.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates AXON as Bearish. Investors should exercise caution and consider a wait-and-see approach before entering the Axon stock due to its recent performance and high valuation metrics.
On the bearish side, Axon's recent earnings misses, particularly the Q1 2026 miss where actual EPS was $1.61 against an estimate of $1.63, indicate challenges in meeting market expectations. Additionally, a high P/E ratio of 153.34 suggests that the stock may be overvalued, particularly in light of its deteriorating EPS growth of -39.57%.
If Axon can reverse its negative EPS growth trend and leverage its impressive revenue growth of 34.00%, it could enhance profitability and attract more investors. The analyst consensus is also optimistic with 25 out of 28 analysts rating the stock as either Strong Buy or Buy, signaling potential upside.
Axon Enterprise Inc's current price of $391.88 is supported by a significant market cap of $31.59B, but the company's weak EPS growth of -39.57% raises concerns about its profitability. Despite a revenue growth of 34.00%, the high P/E ratio of 153.34 suggests the stock may be overvalued given its recent earnings misses, including Q1 2026 where actual EPS of $1.61 fell short of the estimate of $1.63.
Axon Enterprise Inc's current price of $391.88 is supported by a significant market cap of $31.59B, but the company's weak EPS growth of -39.57% raises concerns about its profitability. Despite a revenue growth of 34.00%, the high P/E ratio of 153.34 suggests the stock may be overvalued given its recent earnings misses, including Q1 2026 where actual EPS of $1.61 fell short of the estimate of $1.63. Our overall verdict is Bearish.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for AXON at helmterminal.dev/analyze/AXON, updated continuously during US market hours. No signup required.